Abstract:Background: Endometriosis is associated with chronic, benign, oestrogen-dependent inflammatory disease that affects approximately 10% of reproductive age women and 35-50% of women with pelvic pain and infertility. It can be a weakening disease with dysmenorrhoea, dyspareunia, and chronic pelvic pain symptoms. Objective: To evaluate the role of serum marker (IL-6, IL-8, TNF-α) as non-invasive tool to diagnose endometriosis in reproductive age group. Methods: A case control study was conducted in Department of Obstetrics and Gynecology, KGMU, Lucknow for a period of one year. Total numbers of women enrolled in study were 100. Out of 100 women, 75 women of reproductive age group with clinical suspicion and USG findings were taken as cases. Out of 75 cases, 12 cases lost the follow up and 26 cases kept on conservative management and they responded well. Finally 37 cases of endometriosis with strong clinical suspicions (Dysmenorrhea, Heavy or irregular bleeding, Pelvic pain, Lower abdominal or back pain, Dyspareunia, Dyschezia) and USG finding of endometriosis were recruited as cases and they underwent laparoscopy/ laparotomy. Control group comprises of 25 women undergoing for laparoscopic tubal ligation. After taking informed consent, all the women were subjected to the detailed menstrual, gynaecological, medical history and general, systemic and gynaecological examination. Patient was investigated for haemoglobin, ultrasound abdomen and pelvis and serum markers (IL-6, IL-8, TNF-α). Blood sample (5ml of blood) was collected in vecutainer tube for serum analysis. The blood was centrifuged to separate the serum and stored at -70oC till examined. Finally 37 cases of endometriosis underwent laparotomy/laparoscopy (gold standard to diagnose endometriosis) for proper diagnosis and treatment. Results: Serum IL-8 cut-off at 0.78% pg/ml afforded a sensitivity of 70.3% and specificity of 80% in the diagnosis of endometriosis and has good discriminant ability. TNF-α has average discriminant ability, 62.2% sensitivity and 56% specificity for endometriosis diagnosis. So that serum IL-8 and TNF-α can differentiate cases with or without endometriosis. By detecting these serum markers, we can diagnose endometriosis without undergoing laparoscopy or laparotomy. Conclusion: The serum markers (IL-8, TNF-α) can be used as a non-invasive tool for diagnosis of endometriosis. Key-wordsEndometriosis, Interleukins, Tumour necrosis factor, Laparoscopy INTRODUCTION Endometriosis is the presence of endometrial like tissue (glands/stroma) outside the uterus which induces chronic inflammatory reaction. Endometriosis, multifactorial disease or syndrome that starts around pre pubertal age and flourishes after menarche with symptoms progressive in intensity. Susceptibility of endometriosis depends on complex interaction of immunological, hormonal, environmental & genetic factor. Access this article online Quick Response Code Website:

[Evaluation of Tumor Necrosis Factor-Alpha and Tumor Necrosis Factor-Beta in Serum of Patients with Endometriosis].

Effect of gonadotropin-releasing hormone agonist therapy after laparoscopic conservative surgery with moderate to severe endometriosis

Correlation of Polypeptide N-Acetylgalactosamine Transferases-3 And-6 to Different Stages of Endometriosis

Decreased Levels of Interleukin-18 in Peritoneal Fluid but Not in Serum of Patients with Endometriosis

Expression of TNF-a in Endometrial Cells Exposed to 2,3,7,8-tetrachloro-dibenzo-p-dioxin(TCDD) in Patients with Endometriosis

Decreased Levels of Peritoneal Interleukin-1 Receptor Antagonist in Patients with Endometriosis and Disease-Related Dysmenorrhea.

TGF-β1 Levels in Follicular Fluid of Patients with Endometriosis Associated Infertility

Determination of Interleukin-17 Concentrations in Peritoneal Fluid of Women with Endometriosis

Clinical evaluation of serum CA-125 concentrations in ovary endometriosis patients

Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients.

Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis.

Are cytokine levels in serum, endometrial tissue, and peritoneal fluid a promising predictor to diagnosis of endometriosis-adenomyosis?

Reduced Alternative Splicing of Estrogen Receptor Alpha in the Endometrium of Women with Endometriosis.

Efficacy of Medical Therapy after Conservative Operation for Endometriosis

A comparative study of serum C-reactive protein levels before and after conservative medical treatment in patients with endometrial endometriosis

Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis

Peripheral Biomarkers as Predictive Indicators of Endometriosis: A Prospective Case Control Study

Evaluation of complement system proteins C3a, C5a and C6 in patients of endometriosis

Clinical Study of Effect of Laparoscopic Diagnosis and Treatment on Pelvic Endometriosis-Associated Infertility

Novel Diagnostic Biomarker BST2 Identified by Integrated Transcriptomics Promotes the Development of Endometriosis via the TNF-α/NF-κB Signaling Pathway

Clinical Analysis of Laparoscopic Surgery in the Treatment of 32 Cases of Endometrial Cancer